These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 18767048)
1. The resveratrol analogue 3,5,3',4',5'-pentahydroxy-trans-stilbene inhibits cell transformation via MEK. Lee KW; Kang NJ; Rogozin EA; Oh SM; Heo YS; Pugliese A; Bode AM; Lee HJ; Dong Z Int J Cancer; 2008 Dec; 123(11):2487-96. PubMed ID: 18767048 [TBL] [Abstract][Full Text] [Related]
2. Raf and MEK protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wine. Lee KW; Kang NJ; Heo YS; Rogozin EA; Pugliese A; Hwang MK; Bowden GT; Bode AM; Lee HJ; Dong Z Cancer Res; 2008 Feb; 68(3):946-55. PubMed ID: 18245498 [TBL] [Abstract][Full Text] [Related]
3. Equol, a metabolite of the soybean isoflavone daidzein, inhibits neoplastic cell transformation by targeting the MEK/ERK/p90RSK/activator protein-1 pathway. Kang NJ; Lee KW; Rogozin EA; Cho YY; Heo YS; Bode AM; Lee HJ; Dong Z J Biol Chem; 2007 Nov; 282(45):32856-66. PubMed ID: 17724030 [TBL] [Abstract][Full Text] [Related]
4. Myricetin is a novel natural inhibitor of neoplastic cell transformation and MEK1. Carcinogenesis; ; . PubMed ID: 17693661 [TBL] [Abstract][Full Text] [Related]